Futura Medical Notice of Interim Results

17 September 2021

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, will announce its interim results for the six months ended 30 June 2021 on Wednesday, 29 September 2021.

Read more… 

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...